09/01/2026
Just another indication that we will soon be able to tell people more specifically what their risks for particular diseases are going to be. With that knowledge, they will move research in ways that have never been possible before.
Many diseases begin developing years before symptoms appear[1][1]–[3][2], yet biospecimens from these early stages are rarely available. We developed Chronos, a framework that uses privacy-preserving tokenization[4][3] to link archived plasma samples with longitudinal clinical records, enabling th...